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Abstract 21	
Over-usage of antibiotics leads to the widespread induction of antibiotic resistance 22	
genes (ARGs). Developing an approach to allow real-time monitoring and fast 23	
prediction of ARGs dynamics in clinical or environmental samples has become an 24	
urgent matter. Vibrational spectroscopy is potentially an ideal technique towards the 25	
characterization of the microbial composition of microbiota as it is non-destructive, 26	
high-throughput and label-free. Herein, we employed attenuated total reflection 27	
Fourier-transform infrared (ATR-FTIR) spectroscopy and developed a 28	
spectrochemical tool to quantify the static and dynamic composition of kanamycin 29	
resistance in artificial microbiota to evaluate microbial antibiotic resistance. Second 30	
order differentiation was introduced in identifying the spectral biomarkers, and 31	
principal component analysis followed by linear discriminant analysis (PCA-LDA) 32	
was used for the multivariate analysis of the entire spectral features employed. The 33	
calculated results of the mathematical dispersion model coupled with PCA-LDA 34	
showed high similarity to the designed microbiota structure, with no significant 35	
difference (P >0.05) in the static treatments. Moreover, our model successfully 36	
predicted the dynamics of kanamycin resistance within artificial microbiota under 37	
kanamycin pressures. This work lends new insights into the potential role of 38	
spectrochemical analyses in investigating the existence and trends of antibiotic 39	
resistance in microbiota. 40	
 41	
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Introduction 45	
Antibiotics have played a vital role in modern medicine contributing to a considerable 46	
reduction in childhood mortality and increasing life expectancy1. However, the 47	
increasing number of fatal infections caused by antibiotic-resistant bacteria is 48	
gradually developing into a global threat. The environment has become the primary 49	
“sink” for most applied antibiotics and their residues arising from human or animal 50	
excretion1-3. Since bacteria with antibiotic resistance genes (ARGs) can tolerate 51	
antibiotics, selection pressures from contaminated water or soil will boost the 52	
abundance of ARGs in the environment and increase the possibility of their spread 53	
through microbial species4,5. Therefore, real-time monitoring and quantification of 54	
ARGs or antibiotic-resistant bacteria is urgently required. 55	
Besides measuring the concentration of antibiotics via chemical analysis, various 56	
biological analytical methods have been used to determine the presence, abundance 57	
and diversity of ARGs in the microbiota to capture a “static map” of their existence, 58	
e.g., meta-sequence and quantitative polymerase chain reaction (qPCR)6,7. However, 59	
genetically identical cells from the same population have stochasticity in gene 60	
expression, meaning that there is significant variation in their molecular content and 61	
phenotype, even under similar environmental influences. Moreover, bacterial 62	
resistance to the antibiotics can also be affected and regulated epigenetically8. In 63	
combination, these factors provide an opportunity for phenotypic and cell-type 64	
diversity regardless of genotype9. This questions the reliability of determining ARGs 65	
abundance by molecular biological approaches in real-world situations, leading to the 66	
necessity of developing a phenotypic assay that depicts in situ dynamics of ARGs or 67	
microbial antibiotic resistance in environmental samples. 68	
It is well accepted that genetic and epigenetic factors cannot be studied 69	
independently as a complete phenotype emerges from both together10. The 70	
spectrochemical analysis is an alternative approach to characterize the phenotypic 71	
features of organisms and has already demonstrated its ability to investigate clinical 72	
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samples, as well as to describe and identify bacterial species11,12. Previous studies 73	
indicates that spectroscopic techniques are capable of studying phenotypic features, at 74	
either population13 or single-cell14 level, such as diagnosing the distinct spectral 75	
signatures and metabolomes from isogenic cell lines15. However, the current 76	
techniques have limited application in characterizing ARGs under antibiotic pressures, 77	
mainly due to the lack of appropriate analytical models and well-trained databases. 78	
Recently, some studies using spectroscopic techniques have set out to investigate 79	
biological response to environmental stress, like nanomaterials16,17 and antimicrobial 80	
reagents18,19. The introduction of spectroscopic techniques coupled with a suitable 81	
prediction model to characterize microbial composition may bring new insights in 82	
detecting the presence or even the dynamics of microbial antibiotic resistance in 83	
environmental microbiota in real-time, owing to its non-destructive, high-throughput 84	
and label-free character20,21. It also allows for in situ spectral measurements, helping 85	
in understanding the interactions between microbes and their physical environment. 86	
Kanamycin is a subclass of aminoglycoside antibiotics, one of the most widely 87	
applied antibiotics in health and molecular biology22. Because of the well-established 88	
mechanisms of kanamycin resistance and characterized sequence23, it was selected as 89	
the model antibiotic in the present study. Herein, we used attenuated total reflection 90	
Fourier-transform infrared (ATR-FTIR) spectroscopy, coupled with the multivariate 91	
analysis and the dispersion indicator model, to quantify the kanamycin resistance 92	
within artificial microbiota and evaluate their phenotypic change associated with 93	
kanamycin resistance, from both static and dynamic perspectives. This work raises the 94	
potential feasibility of applying spectroscopic techniques to diagnose ARGs 95	
phenotypic dynamics in the microbial community in situ. 96	
 97	
Experimental section 98	
Sample preparation 99	
The present study included two strains without kanamycin-resistant-gene, 100	
Mycobacterium vanbaalenii PYR-1 and Escherichia coli DH5α, and one 101	
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kanamycin-resistant strain Acinetobacter baylyi ADPWH_recA, which has a 102	
continuously expressed kanamycin resistance gene kanR (from Mini-Tn5/Km24, 103	
Genbank accession number: U32991.1) inserted into the recA gene in the 104	
chromosome of A. baylyi ADP125. Before the experiment, they were all cultured in 105	
Luria-Bertani (LB) broth medium for 24 h at 30±2oC. 106	
The three control groups contained pure M. vanbaalenii PYR-1, E. coli DH5α 107	
and A. baylyi ADPWH_recA, respectively. The artificial microbiotas were prepared 108	
for both static (M1 to M5) and dynamic (AM1 and AM2) experiments by gently 109	
mixing the cells in the compositions listed in Table 1. The optical density at 600 nm 110	
(OD600) in each treatment was monitored continuously for 24 h by a multimode plate 111	
reader (FLUOstar Omega, Germany) to evaluate bacterial growth. For static tests, the 112	
cells were directly collected by centrifugation (4000 rpm for 5 min), washed three 113	
times with sterile deionized water to remove the residues of growth media and then 114	
suspended in 70% ethanol to fix the bacterial cells. For dynamic tests, all the artificial 115	
microbiotas were treated with kanamycin (final concentration 10 mg/L). After 116	
exposure for 4, 8, 12 or 24 h, the cells from microbiotas were harvested following the 117	
same procedure as above. 118	
 119	
Table 1. The compositions of artificial microbiotas (volume ratio, v:v:v). 120	
Treatments 
Control Static test Dynamic test 
M. 
vanbaalenii 
E. 
coli 
A. 
baylyi 
M1 M2 M3 M4 M5 AM1 AM2 
M. vanbaalenii 100% - - 40% 30% 30% 15% 5% 40% 25% 
E. coli - 100% - 50% 45% 20% 10% 5% 40% 25% 
A. baylyi - - 100% 10% 25% 50% 75% 90% 20% 50% 
 121	
ATR-FTIR spectroscopy 122	
The washed cell pellets (minimal amount >5 µL) were applied onto Low-E slides for 123	
the interrogation by ATR-FTIR spectroscopy. A TENSOR 27 FTIR spectrometer 124	
(Bruker Optics Ltd., UK) equipped with a Helios ATR attachment (containing a 125	
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diamond internal IRE; incidence angle of the IR beam: 45°) was used. Instrument 126	
parameters were set at 32 scans and spatial resolution of 8 cm-1. Before the 127	
measurement of a new sample, the crystal was cleaned with deionized water and 128	
background readings were retaken. A total of 30 spectra were randomly acquired for 129	
each treatment (3 replicates). 130	
Computational analysis 131	
The primary analysis methods employed in this study involved multivariate analysis 132	
and the dispersion indicator model. The initial data generated from ATR-FTIR 133	
spectroscopy were analyzed within MATLAB R2011a (TheMathsWorks, Natick, MA, 134	
USA) software, coupled with IRootLab toolbox (http://irootlab.googlecode.com)26. 135	
Unless otherwise stated, the acquired spectra were cut to the biochemical-cell 136	
fingerprint region (1800-900 cm-1), rubberband baseline corrected and normalized to 137	
Amide I (1650 cm-1). Second order differentiation baseline correction and vector 138	
normalization was also performed as an alternative mean to process the data (the 139	
number of the filter coefficients of the Savitzky-Golay smoothing/differentiation filter 140	
was 9). Principal component analysis followed by linear discriminant analysis 141	
(PCA-LDA) was subsequently applied to the pre-processed data to reduce the number 142	
of spectra to 10 uncorrelated principal components (PCs), which account for >99% of 143	
the total variance; LDA is a supervised technique coupled with PCA in order to 144	
maximize inter-class and minimize intra-class variance21. In addition, cluster vector 145	
approach was conducted to visualise the discriminating difference21,27. This method 146	
takes input from PCA-LDA to create a loadings vector for each category contributing 147	
to respective data points. The pseudo-spectra allow identifying which variables (or 148	
wavenumber) are responsible for variance in the data set related to the original 149	
spectra21,27. The detailed information of the dispersion indicator model was described 150	
in the Electronic Supplementary Information (ESI).	151	
Biological analysis 152	
The copy numbers of total bacterial 16S rRNA and targeted kanamycin resistance 153	
gene (kanR) were determined by quantitative polymerase chain reaction (qPCR). For 154	
16S rRNA, the primer pair set was 341F (5’-CCTACGGGNGGCWGCAG-3’) and 155	
805R (5’-GACTACHVGGGTATCTAATCC-3’), and the primer pair for kanR was 156	
KanF (5’-TGTCATACCACTTGTCCGCC-3’) and KanR 157	
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(5’-ATCGAGCTGTATGCGGAGTG-3’). The 20 µL qPCR system consisted of 2 µL 158	
of each primer, 1 µL DNA template, 5 µL molecular water and 10 µL iTaq™ 159	
Universal SYBR® Green Supermix (BioRad, USA). The relative abundance of kanR 160	
in each pure strain was calculated as the ratio of kanR copy numbers to 16S rRNA 161	
copy numbers (kanR/16S). The microbial kanamycin resistance within the artificial 162	
microbiota was calculated as the ratio of A. baylyi population to the total bacterial 163	
population. 164	
Statistical analysis 165	
One-way analysis of variance (ANOVA) with Tukey’s post hoc test/or T-test was 166	
employed to examine the discriminating differences. All statistical analysis was 167	
carried out in GraphPad Prism 6. 168	
 169	
Results and Discussion 170	
Growth and kanamycin resistance gene of individual strains 171	
All the three bacterial strains (A. baylyi ADPWH_recA, M. vanbaalenii PYR-1 and E. 172	
coli DH5α) had similar growth curves without kanamycin pressure (see ESI Figure 173	
S1A). Cultivated in 10 mg/L kanamycin, only A. baylyi ADPWH_recA maintained 174	
positive growth because of the expression of kanR gene and resistance to kanamycin 175	
(see ESI, Figure S1B). Neither M. vanbaalenii PYR-1 nor E. coli DH5α grew 176	
post-exposure to 10 mg/L kanamycin. The results of qPCR further confirmed that the 177	
high relative abundance of kanR gene (kanR/16S) were only found in A. baylyi 178	
ADPWH_recA (0.306 in medium without kanamycin and 0.275 in medium with 10 179	
mg/L kanamycin respectively, no significant difference), whereas it was less than 180	
0.001 or below the limit of detection for M. vanbaalenii PYR-1 or E. coli DH5α (see 181	
ESI, Figure S2). It was further proved that kanamycin resistance gene is only 182	
detectable in A. baylyi ADPWH_recA, but neither M. vanbaalenii PYR-1 nor E. coli 183	
DH5α, and the latter two cannot tolerate kanamycin pressure. The active group of 184	
kanamycin, 2-deoxystreptamine, impairs bacterial protein synthesis through binding 185	
to prokaryotic ribosomes 30S subunit 22. The kanR encoding neomycin 186	
phosphotransferase is an aminoglycoside-modifying enzyme, using ATP as donor to 187	
modify the hydroxyl functions of 2-deoxystreptamine and inhibit its binding to 188	
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ribosomes28. The kanR gene is therefore a reliable molecular indicator in detecting the 189	
kanamycin resistance. 190	
IR spectral fingerprints of individual strains and microbiotas 191	
The IR spectral fingerprint region (1800 - 900 cm-1) of the three strains and artificial 192	
microbiotas are shown in Figure 1. The representative peaks of the biochemical 193	
fingerprint include lipids (~1750 cm-1), Amide I (~1650 cm-1), Amide II (~1550 cm-1), 194	
Amide III (~1260 cm-1), carbohydrate (~1155 cm-1), asymmetric phosphate stretching 195	
vibrations (vasPO2-; ~1225 cm-1), symmetric phosphate stretching vibrations (vsPO2-; 196	
~1080 cm-1), glycogen (~1030 cm-1) and protein phosphorylation (~970 cm-1)20 21. 197	
Past literatures12,20,29,30 suggest the characteristic peaks given by the region can be 198	
used as biomarkers to characterize microbial cell types (even at subspecies level) and 199	
diagnose microbe-induced diseases. 200	
However, the visual spectral differences with the mean spectra are almost 201	
identical regardless of the bacterial species or community composition. For this 202	
reason, we applied the cluster vectors after multivariate analysis (PCA-LDA) and the 203	
second order differentiation baseline correction to further reveal the underlying 204	
biochemical differences between each strain or microbiota. Based on the derived 205	
spectral biomarkers from PCA-LDA (Figure 1B), all the microbiota samples showed 206	
marked segregation (see ESI, Table S1). Characteristics associated with microbial 207	
composition were observed in particular wavenumber-absorbance intensities. For 208	
instance, the intensities at 980 cm-1 and 1740 cm-1 were increased with increasing 209	
ratio of ARGs but fluctuated in some artificial microbiotas, particularly for microbiota 210	
M3 (M. vanbaalenii PYR-1: E. coli DH5α: A. baylyi ADPWH_recA = 211	
30%:20%:50%). Additionally, IR spectral analysis (Figure 2A) based on the second 212	
order differentiation baseline correction and vector normalization highlighted several 213	
key biomarkers. Two apparent shifts from ~1630 cm-1 to ~1640 cm-1 (Amide I) and 214	
from ~1222 cm-1 to ~1235 cm-1 (vasPO2-) associated with A. baylyi were regarded as 215	
biomarkers for the presence of kanamycin resistance. These spectral alterations might 216	
be attributed to the upregulated activities of the kanR encoding aminoglycoside 217	
O-phosphotransferase, which contributes to microbial resistance by inactivating 218	
kanamycin molecular via catalyzing ATP-dependent phosphorylation of specific 219	
aminoglycoside hydroxyl groups31. Some other weaker discriminations included the 220	
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polysaccharide fingerprint region (1000-1150 cm-1) and the protein absorbance region 221	
(1500-1700 cm-1)27. These alterations were probably induced by the interference of 222	
extracellular polymeric substances (EPS) produced by different species32-34 and 223	
resulted in the difficulties in distinguishing biomarkers from the PCA-LDA extracted 224	
peaks. Based on the previous studies32,35,36, we speculate that these extracellular 225	
materials may interact with each other and generate new biochemical compositions 226	
within the communities, influencing the discriminating peaks obtained with 227	
spectrochemical interrogation. 228	
 229	
 230	
Figure 1. (A) Infrared spectra of A. baylyi, M. vanbaalenii, E. coli and five artificial 231	
microbiotas (M1-M5). (B) Cluster vector plots after PCA-LDA, indicating significant 232	
wavenumbers for the segregation between bacterial species and artificial microbiotas. 233	
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 234	
Figure 2. Class means spectra of pre-processed data based on second order 235	
differentiation baseline correction and vector normalization. (A) Processed spectra of 236	
A. baylyi, M. vanbaalenii, E. coli and five artificial microbiotas (M1-M5). (B) 237	
Processed spectra of AM1 at different time point in dynamic experiment. (C) 238	
Processed spectra of AM1 at different time point in dynamic experiment. 239	
 240	
Predicting community composition in artificial microbiotas 241	
Comparing to the IR spectra in the static tests, we observed identical spectral 242	
biomarkers in artificial community dynamics (Figure 2B and 2C) that the same shifts 243	
from ~1630 cm-1 to ~1640 cm-1 (Amide I) and from ~1222 cm-1 to ~1235 cm-1 244	
(vasPO2-) developed along with the time. The results indicated the consistent spectral 245	
biomarkers in both static and dynamic microbiotas in analyzing the phenotypic 246	
presence and abundance of kanamycin resistance gene in the targeted microbiota. 247	
The PCA-LDA scores plot (Figure 3A) also illustrates a significant segregation of 248	
the different groups, associated with differing microbiota compositions. The control 249	
groups (M. vanbaalenii, E. coli, and A. baylyi) are clearly separated from each other. 250	
In contrast to M. vanbaalenii and E. coli, all the converted spectral values of A. baylyi 251	
are aligned as negative along linear discriminant one (LD1), likely attributed to its 252	
kanamycin resistance. Meanwhile, along with linear discriminant two (LD2), the 253	
group of M. vanbaalenii (Gram-positive bacteria) is located on the negative axis alone, 254	
separated from the other two groups (E. coli and A. baylyi), which are Gram-negative. 255	
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The five artificial microbiota samples (M1 to M5) are located inbetween, and their 256	
distances to the control groups are correlated with their community compositions. 257	
 258	
 259	
Figure 3. (A) Two-dimensional (LD1, LD2) scores plot after PCA-LDA of pure 260	
microbial strains and artificial microbiotas with different composition. (B) Correlation 261	
between kanamycin resistance gene abundance and group distance dispersion (𝐷!). (C) 262	
Comparison of artificial microbiota composition between experimental data and 263	
model prediction. 264	
 265	
In order to predict the composition of artificial microbiota, the dispersion indicator 266	
model37 was carried out by transferring the dispersion analysis from the IR spectral 267	
variables to the vectors (LD1 and LD2) and using 𝐷! as the indicator, comparing to 268	
the ARGs gene copy numbers quantified by qPCR as reference. This method used the 269	
summarized spectral information from PCA-LDA which accounts for over 90% of 270	
spectral variations in the present study, and was more conclusive than the limited 271	
biomarkers from second order differentiation. Here, microbiotas with less abundance 272	
of A. baylyi were further separated from the A. baylyi group, but closer to those of E. 273	
coli and M. vanbaalenii, leading to an increasing 𝐷! against the decreasing 274	
kanamycin resistance (kanamycin resistance genes in A. baylyi). Figure 3B illustrates 275	
the negative linear correlation between 𝐷! and the abundance of A. baylyi 276	
(kanamycin resistance gene abundance) within the artificial microbiotas (𝐷! =277	 −0.8482×[𝑘𝑎𝑛𝑎𝑚𝑦𝑐𝑖𝑛 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑔𝑒𝑛𝑒]+ 0.7705). The high coefficient 278	
(R2=0.9779) suggests a good linear regression of 𝐷! against kanamycin resistance. 279	
The composition of each microbiota was, therefore, calculated from the 𝐷! linear 280	
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regression based on PCA-LDA, as shown in Figure 3C. The results indicated that the 281	
predicted microbial compositions had high similarity to their theoretical structure with 282	
no significant differences found (P >0.05). The standard deviation of microbiota M3 283	
(middle point in Figure 3B) was greater than the others, possibly attributing to their 284	
higher Shannon-Wiener index (1.02) than other microbiotas (0.35 to 0.94 for M1, M2, 285	
M4 and M5). Shannon-Wiener index represents the diversity of microbial community, 286	
and higher microbial diversity has been reported to increase complicated 287	
intracommunity interaction32. It might cause huge variation of microbial chemical 288	
composition, consequently leading to the difficulties in interrogating spectral 289	
biomarkers and significant standard deviation in data prediction. 290	
Quantification of kanamycin resistance dynamics within microbiota 291	
Figure 4A illustrates the PCA-LDA scores plot of microbiotas post-exposure to 292	
kanamycin, derived from the spectral dynamics of the artificial microbiotas (see ESI 293	
Figure S3). All the interrogated communities exhibit a dramatic shift from the original 294	
location as the exposure time increases. The M. vanbaalenii category moves towards a 295	
different direction when compared to A. baylyi and E. coli, which might be attributed 296	
to distinct cell structures between Gram-positive (M. vanbaalenii) and Gram-negative 297	
bacteria (A. baylyi and E. coli). Specifically, there is only one lipid bilayer in the 298	
membrane of Gram-positive bacteria, with a thick ring of peptidoglycan and teichoic 299	
acid38,39. On the other hand, the cell membrane of Gram-negative bacteria contains 300	
two lipid associated bilayers, which appear to increase the chance that the applied 301	
treatments influence their structure38,39. The artificial microbiotas, AM1 and AM2, 302	
follow similar trends as the A. baylyi and they come even closer to A. baylyi after 303	
extended exposure to the kanamycin antibiotic. After PCA-LDA, the most 304	
discriminating peaks were observed in Gram-negative bacteria and were attributed to 305	
lipids (~1750 cm-1), vasPO2- (~1225 cm-1) and vsPO2- (~1080 cm-1). Kanamycin’s 306	
antimicrobial mechanism is associated with aminoglycosides, interfering with 307	
aminoacyl-tRNA recognition at the ribosomal A site and disrupting protein 308	
expression40. Such a mechanism causes series of secondary effects, e.g., membrane 309	
damage. Our results are consistent with previous findings showing that the damage is 310	
mainly linked to a broad range of alterations associated with the elements of 311	
membranes, e.g., proteins, supported by derived peaks the protein absorbance region 312	
from 1500 to 1700 cm-1, such as Amide II (~1517 cm-1, ~1543 cm-1) and Amide I 313	
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(~1650 cm-1, ~1680 cm-1)16,21,41,42. 314	
Applying the linear 𝐷! regression model, we successfully predicted the dynamic 315	
abundance of A. baylyi and kanamycin resistance within the microbiotas under 316	
kanamycin antibiotic pressures. Both artificial microbiotas, AM1 (Figure 4B) and 317	
AM2 (Figure 4C), had defined community composition at 0 h, with A. baylyi 318	
(kanamycin resistance gene) accounting for 10% and 40% of the total population, 319	
respectively. Post-exposure to kanamycin, the ARGs abundance from qPCR results 320	
gradually increased to 85.0% in AM1 and 92.2% in AM2 after 12 h, which is 321	
explained by the competitive advantages of bacteria with kanamycin resistance gene 322	
in the community43. It therefore led to a faster growth of A. baylyi compared to other 323	
strains and subsequent dominancy of A. baylyi within the microbiota. From the 324	
dynamics of discriminant functions, the predicted ARGs abundance in both 325	
microbiotas fitted efficiently with experimental data (Figure 4B and 4C). The linear 326	
correlation at each time point did not show significant difference between predicted 327	
and experimental ARGs abundance (Figure 4D), with a Pearson correlation 328	
coefficient of 0.9487. The prediction via infrared spectroscopy coupled and 329	
multivariate analysis fitted the experimental data better at higher ARGs abundance, 330	
but was slightly lower than the qPCR results at low ARGs abundance, e.g., 33% in 331	
Figure 4D, which might underestimate the ARGs abundance to some extent. These 332	
results not only prove that our model can be used for static community composition 333	
and abundance/dynamics of kanamycin resistance gene, but they also evaluate the 334	
impact of antibiotic pressure on kanamycin resistance gene transfer or dominancy. 335	
 336	
 337	
Figure 4. (A) Two-dimensional (LD1, LD2) scores plot after PCA-LDA of IR 338	
dynamics of artificial microbiotas. Dots along with the arrow point in each colour 339	
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refer to the measurement at 0, 4, 8, 12 and 24 h, respectively. The prediction of 340	
kanamycin resistance gene abundance is based on the dispersion among the 341	
classification groups in PCA-LDA for artificial microbiotas AM1 (B) and AM2 (C). 342	
(D) Regression correlation of kanamycin resistance gene abundance between 343	
experimental data via qPCR and model prediction. 344	
 345	
It is worth mentioning that less dispersion is observed for A. baylyi after exposure 346	
because A. baylyi ADPWH_recA contains the kanR kanamycin resistance gene, which 347	
is capable of tolerating kanamycin pressure. In the present study, the kanR kanamycin 348	
resistance gene belongs to npt encoding neomycin phosphotransferase and shows high 349	
similarity to addA encoding aminoglycoside phosphotransferase (aminoglycoside 350	
kinase), which modifies the aminoglycosides by phosphoryl transfer, catalysing the 351	
phosphate addition from ATP to 3'-hydroxyl group40. By expressing kanR, A. baylyi 352	
ADPWH_recA inactivates the interference of protein expression by kanamycin, 353	
achieves fast recovery from suppression, and minimizes spectral alterations as 354	
compared to others. It is confirmed by the presence of consistent shifts and 355	
discriminating biomarkers in A. baylyi postexposure to kanamycin, including Amide I 356	
(~1630 cm-1, ~1640 cm-1) and vasPO2- (~1222 cm-1, ~1235 cm-1)42. 357	
An unexpected decline of kanamycin resistance gene was observed for AM2 358	
artificial microbiota after 24 h exposure to kanamycin (42%, Figure 4C), but the 359	
predicted kanamycin resistance by 𝐷! regression model remained close to 100%. It 360	
might be explained by the dramatically decreasing kanamycin concentration via the 361	
metabolism of aminoglycoside modifying enzyme and the change in microbial 362	
community structure. The functions of kanR encoding aminoglycoside kinase are 363	
stabilizing a metaphosphate transition state and inactivating kanamycin31, and the 364	
spectral alterations represent the alignment disruption of ß-phosphate and γ-phosphate 365	
by amide backbone. The declining kanamycin results in less inhibition on bacteria 366	
without kanamycin resistance gene (M. vanbaalenii and E. coli), and their growth and 367	
regeneration consequently reduce the abundance of A. baylyi and kanR gene. 368	
Alternatively, the FTIR spectral alteration reflects such phenotypic changes of the 369	
whole microbiota under the low kanamycin exposure, illustrating the fact that the 370	
majority of microbial cells within the microbiota have the pseudo-resistance to 371	
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kanamycin. The spectrochemical interrogation therefore actually quantifies the 372	
microbial phenotypic antibiotic resistance rather than the ARGs abundance only. 373	
Infrared spectroscopy has demonstrated the ability to diagnose the phenotypic 374	
alteration of the cellular components induced by kanamycin, hinting its potential 375	
possibility for the application to other members of the aminoglycoside family. Our 376	
findings indicate that this dispersion model coupled with PCA-LDA is a potential 377	
approach for monitoring the population dynamics within a microbiota in real-time. 378	
Additionally, the model applied in the present study summarizes the whole spectral 379	
information derived from the multivariate analysis, rather than only several 380	
biomarkers, showing its potential as a universal predicting tool for a broad spectrum 381	
of antibiotics based on well-trained databases. Though only successfully applied in 382	
the case of kanamycin through phosphotransferase resistance pathway, this technique 383	
is also feasible for detecting N-acetyltransferases and O-nucleotidyltransferases, 384	
which also belong to aminoglycoside-modifying enzymes assisted by 385	
acetyl-coenzyme A and ATP respectively22, attributing to their similar anti-kanamycin 386	
mechanisms as kanR encoding neomycin phosphotransferase. Future work should 387	
refer to more comprehensive range of antibiotics and their mechanisms including 388	
penicillin-class (e.g., ampicillin and amoxicillin), which disrupts the synthesis of 389	
peptidoglycan layer and inhibits bacterial cell wall synthesis 44, and tetracycline, 390	
which inhibits the binding of aminoacyl-tRNA and suppresses protein expression45. 391	
For the urgent need to characterize antibiotic resistance in complex environmental 392	
microbiota with spectroscopy, the primary challenges are raised as the lack of routine 393	
protocols, reproducible computational analysis, and reliable database10. Validated in 394	
the artificial microbiota, our work provides the solutions for the first two barriers by 395	
distinguishing biomarkers representing antibiotic resistance from the numerous 396	
biological fingerprints. A well-built dataset along with robust analytical models 397	
coupled with spectroscopic methods are suggested to address the antibiotic resistance 398	
dynamics in real environmental samples. 399	
The present study indicates that infrared spectroscopy, in conjunction with 400	
multivariate analysis, is a potential tool for diagnosing the phenotypic existence and 401	
dynamics of ARGs within microbial communities. Our work employed ATR-FTIR 402	
spectroscopy coupled with a dispersion model to quantify microbial kanamycin 403	
resistance, based on secondary derivative and PCA-LDA. This method not only 404	
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quantified the static community composition of the artificial microbiotas but also 405	
successfully predicted the population dynamics of microbial communities and 406	
kanamycin resistance under antibiotic pressure. We also suggest that spectroscopic 407	
techniques have great potential in real-time monitoring of microbiota of interest in 408	
medical or environmental fields; this would provide an excellent opportunity to 409	
visualize the vivid phenotypic transformation during a biological and biochemical 410	
process rather than only intermittent snap-shots. 411	
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